Medicine and Dentistry
Fluorescence-Lifetime Imaging Microscopy
100%
Dimer
58%
Heterodimer
50%
Tissue Microarray
41%
Lifespan
33%
Metastatic Breast Cancer
33%
Fluorescence Microscopy
33%
Energy Transfer
33%
Cetuximab
33%
Overall Survival
33%
Breast Cancer
25%
Biological Marker
25%
Hazard Ratio
25%
Epidermal Growth Factor Receptor 2
16%
Targeted Therapy
16%
Pertuzumab
16%
Latent Class Analysis
16%
Oxaliplatin
16%
Epidermal Growth Factor Receptor
16%
Cancer Tissue
8%
Trastuzumab
8%
Tumor Progression
8%
Treatment Response
8%
Combination Therapy
8%
Fluoropyrimidine
8%
Progression Free Survival
8%
Disease Exacerbation
8%
Primary Tumor
8%
Colorectal Carcinoma
8%
Biochemistry, Genetics and Molecular Biology
Fluorescence-Lifetime Imaging Microscopy
100%
Dimerization
50%
Tissue Microarray
44%
Fluorescence Resonance Energy Transfer
33%
Radiation Beam
33%
Fluorescence Microscope
33%
Lifespan
33%
Energy Transfer
33%
Fluorescence Microscopy
33%
Cetuximab
33%
Overall Survival
33%
Pertuzumab
22%
Epidermal Growth Factor Receptor
16%
Trastuzumab
11%
Tumor Progression
11%
Statistical Test
8%
Genetics
8%
Progression Free Survival
8%
Pharmacology, Toxicology and Pharmaceutical Science
Fluorescence-Lifetime Imaging Microscopy
66%
Dimer
58%
Heterodimer
50%
Metastatic Breast Cancer
33%
Chemotherapy
33%
Overall Survival
33%
Cetuximab
33%
Biological Marker
25%
Breast Cancer
25%
Pertuzumab
16%
Epidermal Growth Factor Receptor 2
16%
Epidermal Growth Factor Receptor
16%
Oxaliplatin
16%
Tumor Growth
8%
Trastuzumab
8%
Primary Tumor
8%
Combination Therapy
8%
Fluoropyrimidine
8%
Disease Exacerbation
8%
Colorectal Carcinoma
8%
Progression Free Survival
8%
